Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect
Page 1 of 1
Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect
Jon Moulton Wed Aug 17, 2011 4:42 pm
Senderek J, Müller JS, Dusl M, Strom TM, Guergueltcheva V, Diepolder I, Laval SH, Maxwell S, Cossins J, Krause S, Muelas N, Vilchez JJ, Colomer J, Mallebrera CJ, Nascimento A, Nafissi S, Kariminejad A, Nilipour Y, Bozorgmehr B, Najmabadi H, Rodolico C, Sieb JP, Steinlein OK, Schlotter B, Schoser B, Kirschner J, Herrmann R, Voit T, Oldfors A, Lindbergh C, Urtizberea A, von der Hagen M, Hübner A, Palace J, Bushby K, Straub V, Beeson D, Abicht A, Lochmüller H. Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect. Am J Hum Genet. 2011 Feb 11;88(2):162-72.
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission
» Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS
» A Congenital Neutrophil Defect Syndrome Associated with Mutations in VPS45
» Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome
» Identification of KLHL41 Mutations Implicates BTB-Kelch-Mediated Ubiquitination as an Alternate Pathway to Myofibrillar Disruption in Nemaline Myopathy
» Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS
» A Congenital Neutrophil Defect Syndrome Associated with Mutations in VPS45
» Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome
» Identification of KLHL41 Mutations Implicates BTB-Kelch-Mediated Ubiquitination as an Alternate Pathway to Myofibrillar Disruption in Nemaline Myopathy
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum